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ABSTRACT The development of an injectable probe formulation, consisting of perchlorotriphenylmethyl triester radical dis-
solved in hexaﬂuorobenzene, for in vivo oximetry and imaging of oxygen concentration in tissues using electron paramagnetic
resonance (EPR) imaging is reported. The probe was evaluated for its oxygen sensitivity, biostability, and distribution in a
radiation-induced ﬁbrosarcoma tumor transplanted into C3H mice. Some of the favorable features of the probe are: a single
narrow EPR peak (anoxic linewidth, 41 mT), high solubility in hexaﬂuorobenzene (.12 mM), large linewidth sensitivity to molec-
ular oxygen (;1.8 mT/mmHg), good stability in tumor tissue (half-life: 3.3 h), absence of spin-spin broadening (up to 12 mM), and
lack of power saturation effects (up to 200 mW). Three-dimensional spatial and spectral-spatial (spectroscopic) EPR imaging
measurements were used to visualize the distribution of the probe, as well as to obtain spatially resolved pO2 information in the
mice tumor subjected to normoxic and hyperoxic treatments. The new probe should enable unique opportunities for measurement
of the oxygen concentration in tumors using EPR methods.
INTRODUCTION
Physiologists and clinicians deﬁne hypoxia as a state of re-
duced oxygen availability or decreased partial pressure of
oxygen (pO2) below critical thresholds, thus restricting or
abolishing the normal function of organs, tissues, or cells (1).
In solid tumors, oxygen delivery to the cells is frequently
compromised or inhibited due to poor diffusion geometry,
severe structural abnormalities of tumor microvessels, and
disturbed microcirculation (2). Oxygenation of solid tumors
plays a critical role in the development as well as the treatment
of tumors. Hypoxia can stimulate angiogenesis (3) or increase
the metastatic ability of certain tumors (4,5). Hypoxic cells in
tumors are relatively resistant to radiation, chemo-, or photo-
dynamic therapy (6). A number of key ﬁndings have emerged
on the occurrence of hypoxia in tumors: 1), most tumors have
lower median pO2 than their tissue of origin; 2), many solid
tumors contain areas of low pO2 that cannot be predicted by
clinical size, stage, grade, histology, or site; 3), variability in
oxygenation between tumors is usually greater than intra-
tumor variability; and 4), recurring tumors have a lower oxy-
genation status than the corresponding primary tumors. The
fact that poorly oxygenated tumors are more aggressive and
less susceptible to treatment suggests that tumor oxygenation
status is an important parameter for cancer treatment (7,8).
Further, the observation of substantial inter- and intratumor
heterogeneities among tumors of similar histology and sites
further emphasizes the importance of the measurement of
hypoxia in individual tumor or patients. In addition, the ability
to monitor changes in the pO2 after treatment could have
profound implications in the planning of effective therapeutic
strategies (7,8). In particular, radiotherapy could beneﬁt from
modulated treatment based on regional variations in pO2.
The inﬂuence of tumor oxygenation on treatment outcome
has stimulated the development of a variety of methods for
measuring tumor oxygenation (9–11). The methods include:
paired-survival curve assays of hypoxic fractions (12),
radiation-induced DNA damage measured by ‘‘Comet’’
assay (13), cryospectrophotometric measurements of hemo-
globin oxygen saturation (14), immuno-histochemical de-
tection of nitroimidazole binding (15), polarographic oxygen
electrodes (16), ﬂuorescent and phosphorescent probes
based on oxygen-quenching (17,18), and magnetic reso-
nance methods (19–23). The polarographic electrode is the
only device approved for clinical use, and although invasive,
provides a direct measurement of the oxygen concentration.
Magnetic resonance-based methods, such as nuclear mag-
netic resonance (NMR) and electron paramagnetic resonance
(EPR), have the advantage of noninvasive measurement and
imaging of oxygen concentration in tissues (19,24,25).
The EPR-based method, known as ‘‘EPR oximetry’’, uses
oxygen-sensing spin probes whose EPR lines are broadened
by molecular oxygen. This approach uses either water-
soluble probes such as nitroxyls (26–29) and trityls (21,30–
34) that are administered via vascular routes or water-
insoluble particulates such as India ink (35,36) and lithium
phthalocyanine and derivatives (37–40) that are implanted at
desired sites in the tumor. These probes are stable in tissues,
nontoxic, and biocompatible. The measurements can be per-
formed noninvasively and repeatedly over periods of months
at the same site. There are speciﬁc advantages and disad-
vantages with either approach. The most notable drawbacks
are the requirement of systemic administration and poor
oxygen sensitivity in the case of soluble probes. For the
implanted probes, a notable disadvantage is having to leave
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the particle permanently in the tissue, which may not be
desirable for application in humans. Hence, new approaches
are sought to circumvent these shortcomings. One approach
is to use an implantable and retrievable form of the partic-
ulate probes with a suitable coating, encapsulated in oxygen
permeable ﬁlms (41), or to use locally injectable (intra-
tumoral) formulations (42) that may minimize the risk of
systemic toxicity. The latter approach has the advantage of
using micro-needles for probe delivery to minimize the tissue
injury and trauma associated with the placement of the
probe. However, to achieve optimal signal intensity, biosta-
bility, and oxygen sensitivity of the probe, a diligent choice
of the probe formulation is required. This can be achieved
using a narrow single line probe dissolved in a nonaqueous
solvent having high oxygen solubility and biostability. With
this in mind, we have formulated a new probe, a perchlo-
rotriphenylmethyl radical, dissolved in hexaﬂuorobenzene
(HFB). We used perchlorotriphenylmethyl-triester radical
(PTM-TE, Fig. 1 A), which gives a single narrow EPR line
(Fig. 1 B). The PTM radical and its derivatives are highly
stable against a variety of reactive chemical agents, and
hence are called ‘‘inert free radicals’’ (43,44). They can
withstand temperatures as high as 250C. Their chemical
inertness and thermal stability are due to the full steric
blockage of the central carbon, where most of the spin den-
sity resides (43). HFB has been well established by Mason
et al. (19) as a standalone probe for quantitative tumor
oximetry using 19F-NMR relaxometry. We report, for the
ﬁrst time, the use of a PTM-TE/HFB formulation for high-
resolution oxygen mapping in tumor using EPR spectros-
copy. We have investigated the biostability and oxygen
sensitivity of the probe in a radiation-induced ﬁbrosarcoma
(RIF-1) tumor transplanted in C3H mice. Three-dimensional
spatial and spectral-spatial (spectroscopic) EPR imaging
measurements have been used to visualize the distribution of
the probe, as well as to obtain spatially resolved pO2 in-
formation in the tumor in mice subjected to normoxic and
hyperoxic treatments. The results suggest that the new probe
formulation enables imaging of the absolute values of ox-
ygen concentration in tumors with remarkable sensitivity
under minimally invasive conditions.
MATERIALS AND METHODS
Reagents
Perchlorotriphenylmethyl radical (PTM-TE) was synthesized as reported
(45). Hexaﬂuorobenzene (HFB) was purchased from Apollo Scientiﬁc
(Stockport, Cheshire, UK).
Calibration of EPR oximetry
PTM-TE was dissolved in HFB to a ﬁnal concentration of 1 mM and was
loaded in a 0.8 mm diameter gas-permeable Teﬂon tube (Zeus Industrial
Products, Orangeburg, SC). The Teﬂon tube was inserted into a 3-mm quartz
EPR tube, which was placed in the resonator. Premixed oxygen and nitrogen
gases of known concentrations were ﬂown through the EPR tube attached
to a gas ﬂow meter. The oxygen concentration was varied from 0 to 100%.
All measurements were taken after equilibrating the sample with the gas
mixture. The peak-to-peak linewidth (DBpp) of the EPR spectrumwere plotted
against pO2 to determine the oxygen sensitivity.
PTM-TE probe properties
The microwave power saturation of the EPR signal, the effect of concen-
tration on the signal intensity and linewidth (spin-spin interaction), and the
stability of PTM-TE in HFB were studied at room temperature using X-band
(9.8 GHz) EPR spectroscopy.
Animals
Female C3Hmice were obtained from the Frederick Cancer Research Center
Animal Production Facility (Frederick, MD). The animals were housed ﬁve
per cage in a climate- and light-controlled room. Food and water were
allowed ad libitum. The animals were 50 days old and weighed;25 g at the
time of the experiment. The mice were anesthetized with ketamine and
xylazine (i.p.) and inhaled either room air (21% O2) or carbogen (mixture
of 95% O2 and 5% CO2) through a nose cone. During the measurements, the
body temperature of the animal was monitored using a rectal thermistor
probe and maintained at 376 1C by an infrared lamp placed just above the
animal. The experimental protocol used in this study was approved by the
Institutional Animal Care and Use Committee of the Ohio State University
and conformed to the Guide for the Care and Use of Laboratory Animals
(NIH Publication No. 86-23).
RIF-1 tumor growth
Radiation-induced ﬁbrosarcoma-1 (RIF-1) cells were grown in RPMI
medium 1640 supplemented with 10% fetal bovine serum and 1% penicillin/
streptomycin in an atmosphere of 95% air and 5% CO2 at 37C. Cells were
trypsinized, centrifuged, and suspended in PBS. The cells (1 3 106) were
injected subcutaneously into the upper portion of the right hind limb of C3H
mice and grown as solid tumor. All measurements were performed on
tumors from 200 to 300 mm3 in volume.
EPR measurements in tissues
A 15–20 mL aliquot of 12 mM PTM-TE in HFB was injected intramuscu-
larly (n ¼ 3) or intratumorally (n ¼ 3) at a depth of ;2 mm using 30-gauge
FIGURE 1 (A) Chemical structure of perchlorotriphenylmethyl triester
radical (PTM-TE) and (B) its EPR spectrum in hexaﬂuorobenzene (HFB)
measured under room air conditions (20.9% oxygen). The peak-to-peak
linewidth is 0.321 mT.
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needles while the mice were under ketamine/xylazine anesthesia. The oxy-
gen concentration in the normal and tumor tissue was measured using an
L-band (1.2 GHz) EPR spectrometer with a loop coil (Magnettech, Berlin,
Germany). The frequency of the L-band spectrometer is optimal for animal
studies due to microwave absorption and penetration within tissues.
EPR imaging
The in vivo EPR imaging measurements were performed by using a home-
built L-band (1.2 GHz) EPR spectrometer with a bridged loop-gap resonator
(26). Mapping of the probe (PTM-TE) location and the oxygen concentra-
tion in the tumor was obtained by spatial and spectroscopic (spectral-spatial)
EPR imaging methods that are well established in our laboratory (26,37).
The principle of EPR mapping of pO2 is based on the oxygen-dependent
linewidth data from each voxel in the object. A notable caveat is that the pO2
information can only be obtained from those voxels that have measurable
EPR signal intensity. Thus pO2 values are not obtained from those voxels
within the ﬁeld of view (FOV) that either have no signal, or signal intensities
less than threshold set at 30% of maximum signal intensity. The voxels with
undetermined pO2 values are coded with black color. The following param-
eters were used for EPR image acquisition: sweep time, 4 s; modulation
amplitude, 18 mT; time constant, 0.04 s; microwave power, 5 mW; FOV,
20 mm; number of projections, 144 or 256. The sweep width was 1 mT for
spatial imaging while it was variable for spectroscopic (spectral-spatial)
imaging. The spectroscopic imaging used a spectral window ((FOV) of
0.5 mT. Computer software based on MatLab Software (The MathWorks,
FIGURE 2 Effect of pO2 on the linewidth of PTM-TE in HFB. The peak-
to-peak linewidth of 1 mM PTM-TE in 50 mL of HFB was measured using
an X-band EPR spectrometer under different oxygenation conditions as
described in Materials and Methods. The linewidth data, expressed as mean
6 SD from three independent measurements, showed a linear variation with
pO2 (solid line, R
2 ¼ 0.98) with a sensitivity of 1.771 mT/mmHg in the
0–760 mmHg range. The inset shows the dependence of linewidth on oxygen
concentration in the physiological range.
FIGURE 3 Time response of linewidth of PTM-TE in HFB to changes
in oxygen concentration. The EPR spectrum of PTM-TE (1 mM PTM-TE in
50 mL HFB) was measured continuously using 5-s scans while the oxygen
content in the ﬂowthrough gas mixture was switched between 0% and 21%,
at;15-min cycles, as indicated. The response of the peak-to-peak linewidth,
shown as a solid line connecting the measured values to changes in oxygen
concentration, was reproducible for several cycles of oxygenation and
reoxygenation.
FIGURE 4 Stability of PTM-TE in normal and tumor tissues. A small
volume (20 mL) of 12 mM PTM-TE in HFB was injected directly into
muscle or RIF-1 tumors grown in the hind leg of C3H mice and the intensity
of the EPR signal was continuously measured using an L-band EPR spec-
trometer for up to 10 h. The plot (A) shows the time-course of EPR intensity
data (relative to respective initial reading, displayed on a logarithmic scale)
obtained from three mice per group. The decay half-life of PTM-TE was
3.36 0.4 h in tumor and 2.36 0.5 h in muscle. The plot (B) shows changes
in the linewidth of the EPR signal during the measurement period. No sig-
niﬁcant change in the linewidth was observed.
2920 Bratasz et al.
Biophysical Journal 92(8) 2918–2925
Natick, MA) was developed to compute pO2 values from the image data.
The calibration curve was corrected according to linewidth values obtained
at room air and under anoxic conditions using the L-band EPR spectrometer.
The software used an automated ﬁtting of the lineshape data to a Lorentzian
function and converted the linewidth to pO2 using a standard oximetry
curve. The output of the result was a 256 color-coded 64364 grid image
of pO2. A linear interpolation was used in the hardcopy (high-resolution)
representation of the images.
Statistical analysis
Data are expressed as mean6 standard deviation (SD). Comparisons among
groups were performed using the Student’s t-test with the level of signif-
icance (P) set at 0.05.
RESULTS AND DISCUSSION
EPR properties of PTM-TE
PTM-TE is insoluble in aqueous solutions. However, it is
soluble in many nonpolar solvents including HFB. PTM-TE
in HFB exhibits a single line EPR peak with a peak-to-peak
linewidth (DBpp) of 0.321 mT under indoor ambient
conditions (Fig. 1 B). The linewidth is highly sensitive to
the concentration of molecular oxygen in the solution. As
shown in Fig. 2, the linewidth of PTM-TE exhibits a linear
relationship with pO2 in the measured range of 0–760
mmHg. The sensitivity of oxygen-induced line-broadening
is 1.771 mT/mmHg, which is .50 times higher than that of
water-soluble nitroxyls and trityls (34). This value is also
higher when compared to the sensitivity of particulate probes
such as lithium phthalocyanine (38,39) and lithium butoxy-
naphthalocyanine (40). The high sensitivity of the formula-
tion for oxygen can be due to the high solubility of oxygen
in HFB. The solubility at atmospheric pressure (21% of
oxygen) at 25C is 270 mM in water and 4400 mM in HFB
(46). No spin-spin broadening was observed for up to a 12
mM concentration (solubility limit) of PTM in HFB (data not
shown). Power saturation studies demonstrated that the
anoxic spectrum was not signiﬁcantly saturated up to 1 mW
of incident power (at 9.78 GHz), while the spectrum in
normoxic (room air-equilibrated, DBpp ¼ 321 mT) solutions
was not saturated up to 200 mW (data not shown). The
radical was observed to be stable in HFB in the dark.
However, in the presence of visible or UV light, a decay of
FIGURE 5 Three-dimensional im-
ages of the distribution of PTM-TE in
tumor as a function of time. A solution
of 12 mM PTM-TE in HFB (20 mL)
was directly injected into a RIF-1 tumor
grown in the hind limb of C3H mice at
a depth of ;2 mm using a 30-gauge
needle. Three-dimensional spatial EPR
images were obtained as a function of
time as indicated. The top panels (203
20 3 20 mm3) show the time-course
visualization of three-dimensional im-
ages at 30% background transparency.
The following three rows show the
time-course images of PTM-TE in three
orthogonal slices (XY, YZ, and ZX)
intersecting at the center of the three-
dimensional image. The images were
reconstructed from 256 projections,
acquired using a magnetic ﬁeld gradient
of 250 mT/m.
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the EPR signal was observed. However, light had no effect
on the oxygen-sensing characteristics of the probe.
The time-response of the linewidth to acute changes in
oxygen concentration was evaluated by continuously mea-
suring the EPR spectrum of PTM-TE (1 mM in 50 mL of
HFB contained in a gas-permeable Teﬂon tubing), while the
oxygen content in the ﬂowthrough gas mixture was switched
between 0% and 21%. The response of the peak-to-peak
linewidth to changes in oxygen concentration was highly
reproducible for several cycles of deoxygenation and re-
oxygenation (Fig. 3). No signiﬁcant differences in the rates
of change in linewidth were observed between the oxygen-
ation (t1/2 ¼ 2.36 0.5 min) and deoxygenation (t1/2 ¼ 2.56
0.3 min) processes.
Stability and distribution of PTM-TE in tissue
To evaluate the stability of the probe solution in normal
tissue and tumor, a 20 mL solution of 12 mM PTM-TE in
HFB was directly injected into muscle or RIF-1 tumors using
a 30-gauge needle at a depth of ;2 mm. The animals were
placed in the L-band EPR resonator and the decay of the
PTM-TE signal intensity was measured for up to 9 h post-
injection. As shown in Fig. 4 A, the intensity of the EPR
signal decreased with time. The data were suggestive of an
exponential decay with a half-life of 3.36 0.4 h in the tumor
tissue and 2.3 6 0.5 h in muscle. To address the possibility
of diffusion of PTM-TE out of the HFB vehicle into en-
dogenous environments with different oxygen solubility we
monitored the linewidth data of PTM-TE/HFB in the normal
muscle and tumor tissue. As shown in Fig. 4 B, there was no
signiﬁcant change in linewidth during the 8-h observation
period, suggesting that the probe did not diffuse out of HFB.
The three-dimensional distribution of PTM-TE/HFB ﬂuid
in the solid tumor was determined by EPR imaging. A
solution of 12 mM PTM-TE in HFB (20 mL) was directly
injected into the 200–300 mm3 transplanted RIF-1 tumors.
The animals were placed in the L-band EPR resonator and
three-dimensional spatial EPR images were obtained. Fig. 5
shows the time-course images of PTM-TE distribution in a
tumor (of ;200 mm3 volume) obtained at 20-min intervals
for 80 min. The maximum volume of distribution of the
image at the 30% background threshold cutoff was estimated
to be 29.3 mm3, which is ;15% of the tumor size. It was
observed from the three-dimensional image, as well as from
the change in the concentration of PTM-TE in the three
orthogonal slices shown as a function of time, that the
volume of distribution was fairly unchanged with time. This
suggests that the signal decay may be primarily due to loss of
PTM-TE and not due to diffusion or clearance of the carrier
(HFB) from the site of observation. This observation was
also consistent with the longer decay half-life of HFB in
tumor tissue (20). Mason et al. (19) have reported that after
intratumoral injection in a Dunning prostate tumor in a rat,
HFB is distributed in the form of ﬁne droplets, while our
images showed the presence of a continuous distribution.
The appearance of a continuous distribution in our study may
be attributed to the poor spatial resolution (;0.5 mm) of the
image, which was mainly due to poor signal/noise ratio of
the signal. Assuming that 20 mL of 12 mM PTM-TE was
distributed in a volume of 29.3 mm3, the effective concen-
tration of the paramagnetic probe was estimated to be only
8 mM in the tissue. This explains the absence of discrete
regions of PTM-TE in the EPR images. This limitation can
be overcome using larger volume of the probe or by using
fewer acquisitions to obtain a higher signal/noise ratio.
Tumor pO2 and its dependence on FiO2
To check the effect of modulation of fractional percentage of
inspired oxygen (FiO2) on the tumor pO2 measured using the
peak-to-peak linewidth of the EPR spectrum, experiments
were performed in tumor-bearing mice under normal (air-
breathing) and hyperoxygenated (carbogen-breathing) con-
ditions. A solution of 12 mM PTM-TE in 20 mL of HFB was
directly injected into the tumor and the tumor oxygenation
was continuously measured during cycles of air- and carbogen-
breathing. A representative time-course measurement of tumor
FIGURE 6 Effect of FiO2 on the tumor pO2. A solution of 20 microliters
of PTM-TE (12 mM in HFB) was injected directly into RIF-1 tumor grown
in the hind leg of a C3H mouse. (A) Change in pO2 in the tumor of a single
animal while the FiO2 was successively switched between 21% and 95%
(carbogen gas), as indicated. (B) The pO2 values obtained before (FiO2 ¼
21%) and 20 min after changing the FiO2 to 95% in ﬁve different animals.
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pO2 is shown in Fig. 6 A. The tumor pO2 increased during
carbogen-breathing and the effect of cycling between normal
and hyperoxygenated gas was fairly reproducible, although
the exact rates and levels of oxygenation were not the same
between the cycles. It is well known that tumor oxygenation
and its change during hyperoxic challenge are highly variable
depending on the site of examination in the tumor (19,47).
This was also evident from the results of the above mea-
surements in ﬁve different animals shown in Fig. 6 B, where
both the normoxic and hyperoxic treatments demonstrated
different levels of oxygenation.
Since the RIF-1 tumors are known to have signiﬁcant
heterogeneity in oxygenation (48), the 15% volume covered
by the probe is expected to have nonuniform regions of
oxygenation. Hence, a spectroscopic determination (single
readout) of pO2 may reveal only a single value, which is
often an overestimate of the hypoxic value due to the use of
peak-to-peak linewidth. Hence, one needs to use imaging
methods to resolve, spatially, the regional differences in the
oxygenation.
Mapping of pO2 distribution in the tumor
To resolve the oxygen distribution within the region of
PTM-TE/HFB in the tumor, we performed three-dimensional
spectroscopic imaging. The tumor-bearing mice were allowed
to breathe room air and the EPR spectral-spatial images were
collected. Then the same animals were allowed to breathe
carbogen gas (95% O2 and 5% CO2) for 20 min before im-
ages were collected. The spatial and oxygen images obtained
under these two conditions are shown in Fig. 7. The pO2 data
from the tumor of an air-breathing mouse showed signiﬁcant
distribution both in the magnitude and frequency of occur-
rence within the examined volume. In general, the values
were hypoxic (mean pO2 ¼ 10.6 mmHg; median pO2 ¼ 5.0
mmHg) and right-skewed, which is characteristic of this type
of tumor (49). Carbogen-breathing by the mouse increased
both the mean and median tumor pO2 values (mean pO2 ¼
11.7 mmHg; median pO2 ¼ 6.9 mmHg).
HFB is well characterized in terms of a lack of toxicity,
exhibiting no mutagenicity, teratogenicity, or fetotoxicity
(50). The Material Safety Data Sheet indicates LD50 . 25
g/kg (oral administration in rat) and LC50 95 g/m
3/2h
(inhalation by mouse). HFB had been proposed as a veter-
inary anesthetic and has been used in many species including
ponies, sheep, cats, dogs, rats, and mice, but was abandoned
due to its high volatility (boiling point 81C) and low ﬂash
point (10C) (51,52). Song et al. (53) have established HFB
as a stand-alone probe for quantitative tumor oximetry using
19F-NMR relaxometry and echo planar magnetic resonance
imaging (MRI). The MRI measurements using HFB in
Dunning prostate tumors in rats revealed signiﬁcant right-
skewness with low mean pO2, when animals were breathing
33% oxygen, which increased with a rise in the FiO2 in the
breathing gas (54). Since this formulation consisted of a
combination of EPR oximetry probe, PTM-TE, and NMR/
MRI oximetry probe, HFB, it is also possible to perform
multimodality (EPRI/MRI) oxygen imaging as well as anat-
omical map (MRI) with minimal invasiveness and systemic
toxicity.
We thank Dr. Christophe Buron for synthesis of the PTM-TE probe and
Brian Rivera for critical reading of the manuscript.
FIGURE 7 Images of the distribution
of PTM-TE and oxygen concentration
in tumor. A 20-mL solution of 12 mM
PTM-TE in HFB was directly injected
into a RIF-1 tumor (size ¼ 200 mm3),
grown in the hind limb of C3H mice, at
a depth of ;2 mm using a 30-gauge
needle and three-dimensional spectral-
spatial (spectroscopic) EPR images
were obtained while the animal was
breathing either room air or carbogen
gas. The images (15 3 15 mm2) were
reconstructed from 144 projections ac-
quired using a maximum magnetic ﬁeld
gradient of 500 mT/m. The probe is
distributed in;10% of the tumor. Note
that the oxygen information is obtained
only from the regions where the probes
are present. The pO2 values in the air-
breathing animal are hypoxic (mean
pO2 ¼ 10.6 mmHg; median pO2 ¼ 5.0
mmHg) and signiﬁcantly right-skewed.
Carbogen-breathing increased both the
mean and median pO2 values (mean
pO2 ¼ 11.7 mmHg; median pO2 ¼ 6.9
mmHg) in the tumor.
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